Table 2.
The median (IQR) peak pain (VAS), pain duration (s) and pain area (au) after injections
| Hypertonic saline side | Control side | |
|---|---|---|
| Peak pain | ||
| All |
52.5 (38.0) |
7.5 (24.0)* |
| Men |
50.0 (30.3) |
0.0 (24.3)* |
| Women |
56.0 (50.5) |
15.0 (22.0)* |
| Pain duration | ||
| All |
345 (150) |
8 (45)* |
| Men |
405 (170) |
0 (64)* |
| Women |
315 (131) |
15 (45)* |
| Pain area | ||
| All |
54 (65.0) |
0 (3.0)* |
| Men |
46 (69.3) |
0 (2.3)* |
| Women | 60 (87.8) | 0 (5.5)* |
Table shows data from thirty healthy participants, 15 men and 15 aged-matched women.
IQR = interquartile range (75 percentile minus 25 percentile) VAS = 100 mm visual analogue scale * = significant difference between sides (p < 0.001). There were no significant differences between sexes.